Dynavax Technologies Corp (DVAX)
11.42
-0.34
(-2.89%)
USD |
NASDAQ |
Apr 24, 16:00
11.42
0.00 (0.00%)
After-Hours: 20:00
Dynavax Technologies Market Cap: 1.492B for April 24, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 1.492B |
| April 23, 2024 | 1.536B |
| April 22, 2024 | 1.546B |
| April 19, 2024 | 1.541B |
| April 18, 2024 | 1.481B |
| April 17, 2024 | 1.493B |
| April 16, 2024 | 1.501B |
| April 15, 2024 | 1.527B |
| April 12, 2024 | 1.546B |
| April 11, 2024 | 1.569B |
| April 10, 2024 | 1.561B |
| April 09, 2024 | 1.570B |
| April 08, 2024 | 1.574B |
| April 05, 2024 | 1.574B |
| April 04, 2024 | 1.578B |
| April 03, 2024 | 1.592B |
| April 02, 2024 | 1.608B |
| April 01, 2024 | 1.643B |
| March 28, 2024 | 1.621B |
| March 27, 2024 | 1.621B |
| March 26, 2024 | 1.616B |
| March 25, 2024 | 1.633B |
| March 22, 2024 | 1.605B |
| March 21, 2024 | 1.588B |
| March 20, 2024 | 1.580B |
| Date | Value |
|---|---|
| March 19, 2024 | 1.570B |
| March 18, 2024 | 1.528B |
| March 15, 2024 | 1.574B |
| March 14, 2024 | 1.570B |
| March 13, 2024 | 1.590B |
| March 12, 2024 | 1.651B |
| March 11, 2024 | 1.694B |
| March 08, 2024 | 1.716B |
| March 07, 2024 | 1.674B |
| March 06, 2024 | 1.663B |
| March 05, 2024 | 1.642B |
| March 04, 2024 | 1.664B |
| March 01, 2024 | 1.667B |
| February 29, 2024 | 1.655B |
| February 28, 2024 | 1.691B |
| February 27, 2024 | 1.697B |
| February 26, 2024 | 1.716B |
| February 23, 2024 | 1.665B |
| February 22, 2024 | 1.625B |
| February 21, 2024 | 1.627B |
| February 20, 2024 | 1.604B |
| February 16, 2024 | 1.607B |
| February 15, 2024 | 1.617B |
| February 14, 2024 | 1.617B |
| February 13, 2024 | 1.592B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
175.27M
Minimum
Jul 30 2019
2.512B
Maximum
Nov 03 2021
1.157B
Average
1.293B
Median
Apr 11 2022
Market Cap Benchmarks
| Supernus Pharmaceuticals Inc | 1.656B |
| Ligand Pharmaceuticals Inc | 1.257B |
| Pacira BioSciences Inc | 1.204B |
| Esperion Therapeutics Inc | 394.16M |
| PetIQ Inc | 482.67M |
Market Cap Related Metrics
| PS Ratio | 6.928 |
| Price to Book Value | 2.398 |
| Price to Free Cash Flow | 16.68 |
| Price | 11.42 |
| Earnings Yield | -0.53% |
| Normalized PE Ratio | 1045.98 |